Dec 05, 2023
135:128
For every 128 shares held, investors received 135. The price per share adjusted from $0.41 to $0.38.
The split itself did not change the total investment value.
Mesoblast Limited (ASX:MSB) operates in the Biotechnology industry.
Mesoblast Limited company overviewMesoblast Limited's most recent stock split was on December 5, 2023. It was a 135-for-128 forward split, so shareholders received 135 shares for every 128 they held.
Mesoblast Limited (ASX:MSB) has split its stock 2 times: a 299-for-296 split on August 29, 2017 and a 135-for-128 split on December 5, 2023.
Mesoblast Limited has split its stock 2 times. This history records 2 forward splits between August 29, 2017 and December 5, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Mesoblast Limited's 135-for-128 split on December 5, 2023, every 128 shares became 135 shares.
Mesoblast Limited has not announced a new split in our records. Its most recent split was on December 5, 2023, 2 years ago. Companies announce splits in advance, and any new ASX:MSB split will appear on this page.
Already premium?